We are pleased to announce that the NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2021 cohort. The overarching goal of the CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. Our focus is on investigators who have not previously designed their own prospective, interventional clinical trials.
Course:
Due to the uncertainty and variations nationwide with the pandemic restrictions and vaccine availability the CTMC External Advisory Board and Course Directors decided that the 2021 Course will be virtual. The 2021 Course will begin late April through November, including an intense portion from July 19-22. Attendance is REQUIRED for the intense portion and the schedule will take into consideration the virtual format.
In addition, the 2021 cohort will have training opportunities in 2022 with ongoing support through mentorship. Since we anticipate being able to resume with in-person activities in 2022 the 2021 cohort will have the unique opportunity to attend the in-person residential portion of the Course in July 2022. This will allow for networking, peer review experience, and additional time and instruction with CTMC esteemed faculty. (More details will be provided late next year).
Who Should Apply?
Qualified applicants from clinical disciplines focused on neurological disease or injury (including, but not limited to pediatric and rare diseases), along with biostatisticians working on projects with clinical neuroscience researchers should apply. All preliminary trial ideas are encouraged, but it is REQUIRED that protocols be focused on the clinical neurosciences. Trainees should have content area mentors to assist them with the science and implementation of their project. A small number of projects may qualify for additional work using clinical trial simulation.
DEADLINE:
The application submission deadline is February 28, 2021 at midnight, Pacific Time. Application forms and additional details are available on the course website. Early applications may be considered for early acceptance.